Biotech Values

[DewDiligence]

[GTCB] U.S. ATryn program close to being restarted:

http://biz.yahoo.com/bw/040805/55183_1.html

It’s a good sign when a specific time period is given (next three months):

>>
GTC is continuing discussions with the Food and Drug Administration (FDA) regarding a clinical protocol for ATryn® in the United States in the HD indication. Following these discussions, GTC plans to submit an amended Investigational New Drug (IND) application during the next three months. An IND had been previously filed to include US patients in the clinical trials that were submitted to the EMEA.
<<

GTCB CC today at 10 a.m. ET.